並列タイトル等A Phase 1, Randomized, Placebo-Controlled Study of Molnupiravir in Healthy Japanese to Support Special Approval in Japan to Treat COVID-19
一次資料へのリンクURLhttps://our.repo.nii.ac.jp/record/2012876/files/ko_689.pdf
著作権情報The final publication is available at https://doi.org/10.1111/cts.13395. Keisuke Nakamura, Katsukuni Fujimoto, Chihiro Hasegawa, Ikuo Aoki, Hiroyuki Yoshitsugu, Hiroyuki Ugai, Naoyoshi Yatsuzuka, Yoshiyuki Tanaka, Kenichi Furihata, Brian M. Maas, Prachi K. Wickremasingha, Kelly E. Duncan, Marian Iwamoto, Selwyn A. Stoch, Naoto Uemura. Clinical Trial Clin Transl Sci. 2022 Nov;15(11):2697-2708
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. Copyright 2022 Merck Sharp & Dohme LLC and The Authors. Clinical and Translational Science published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics.
連携機関・データベース国立情報学研究所 : 学術機関リポジトリデータベース(IRDB)(機関リポジトリ)